Ziprasidone
Suppliers
Names
[ CAS No. ]:
146939-27-7
[ Name ]:
Ziprasidone
[Synonym ]:
5-{2-4-(1,2-benzothiazol-3-yl)piperazin-1-ylethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
ziprasidonum
Ziprasidone
UNII-6UKA5VEJ6X
5-{2-[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
ziprasidona
EINECS 203-794-9
5-{2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chlor-1,3-dihydro-2H-indol-2-on
Zipwell
MFCD00866661
2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-
2H-indol-2-one, 5-2-4-(1,2-benzisothiazol-3-yl)-1-piperazinylethyl-6-chloro-1,3-dihydro-
5-{2-[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
ziprazidone
Ziprasidone [INN:BAN]
Geodon
Zeldox
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
Chemical & Physical Properties
[ Density]:
1.4±0.1 g/cm3
[ Boiling Point ]:
554.8±50.0 °C at 760 mmHg
[ Melting Point ]:
213-215°C
[ Molecular Formula ]:
C21H21ClN4OS
[ Molecular Weight ]:
412.94
[ Flash Point ]:
289.3±30.1 °C
[ PSA ]:
76.71000
[ LogP ]:
4.00
[ Vapour Pressure ]:
0.0±1.5 mmHg at 25°C
[ Index of Refraction ]:
1.681
[ Storage condition ]:
Refrigerator
MSDS
Safety Information
[ Symbol ]:
GHS02, GHS07, GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H225-H315-H360FD
[ Supplemental HS ]:
May form explosive peroxides.
[ Precautionary Statements ]:
P201-P210-P308 + P313-P403 + P235
[ Hazard Codes ]:
C,N
[ Risk Phrases ]:
R22:Harmful if swallowed. R34:Causes burns. R50/53:Very Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment . R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .
[ Safety Phrases ]:
S26-S36/37/39-S45-S60-S61
[ RIDADR ]:
UN 3259 8/PG 3
[ WGK Germany ]:
2
[ RTECS ]:
JR6475000
[ Packaging Group ]:
II
[ Hazard Class ]:
8
[ HS Code ]:
29211980
Customs
[ HS Code ]: 29211980
Articles
BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013)
The patient is a 52-year-old man with schizophrenia who developed severe, unremitting gingival pain after his ziprasidone dosage was increased from 80 to 120 mg. His physical examination and laborator...
J. Clin. Psychopharmacol. 33(1) , 3-10, (2013)
The potential for iloperidone, a D2/5-HT2A antipsychotic, to affect the heart rate-corrected QT interval (QTc) was assessed in the absence and presence of metabolic inhibitors in a randomized, open-la...
J. Adolesc. Health 52(3) , 336-43, (2013)
To assess the association of second-generation antipsychotics (SGAs) with changes in body mass index (BMI) among adolescents compared with a matched untreated comparison group.A retrospective cohort s...